Parameter
| Biomarker | NLR | Full name | Neutrophil-to-Lymphocyte Ratio | Molecular Type | Inflammatory markers (cell ratios) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis |
| Disease | Renal Cell Carcinoma(RCC) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Whole blood (complete blood count) | ||
| Pathobiological Mechanisms | Reflects systemic inflammatory status, with anti-tumor immune suppression mediated by inflammation | ||||
| Clinical Availability Status | Clinically available / Research support: Multiple meta-analyses have confirmed its prognostic value | ||||
| Notes and Dynamics | NLR>4.0 suggests limited benefit of cytoreductive nephrectomy | ||||